Search

everythinglearnresearchcommunity

for

Search:↓

Experts met to improve care for ichthyosis patients in Spain.

Hyaluronic Acid Profhilo® reduces skin inflammation and nerve-related pain in atopic dermatitis.

Combining surgical and nonsurgical methods is key to reducing post-burn scars.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Acne may signal underlying metabolic issues, and lifestyle changes can help manage both.

Comprehensive genetic testing and international collaboration are crucial for better understanding and managing Ehlers-Danlos syndromes.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Peptide hydrogels show promise for healing skin, bone, and nerves but need improvement in stability and compatibility.

Biopolymers are increasingly used in cosmetics for their non-toxicity and skin benefits, with future biotech advancements likely to expand their applications.

More research is needed to understand how testosterone is maintained in adult males.

Beards and long hair may affect how attractive someone is to the opposite sex.

Divalproex sodium can unexpectedly cause agitation and hyperactivity in some patients.

Frontal fibrosing alopecia mainly affects postmenopausal women and may be linked to thyroid hormones.

A man with a rare disease experienced late hair whitening and loss, but hair color returned, suggesting a good outlook.

COVID-19 can cause temporary hair loss due to stress and inflammation.

Vibration assisted analgesia reduces pain during corticosteroid therapy for alopecia.

Telogen effluvium is a type of hair loss in women caused by many factors, and iron and thyroid tests are recommended for diagnosis.

Post-bariatric surgery patients often face gastrointestinal issues, fatigue, dry skin, hair loss, and anxiety.

Only about 20% of women have hair loss after childbirth severe enough to be considered clinically significant.

The document concludes that there are no effective clinical treatments for hearing loss due to hair cell damage, but research is ongoing.

Many patients with hair loss had low iron and vitamin D levels, but thyroid issues were not common.

Telogen effluvium is a common hair loss where hair sheds due to stress but new hair still grows.

Hair is thinner near the scalp in acute hair shedding conditions.

An 11-year-old girl with Kawasaki disease experienced hair loss that improved after treatment.

COVID-19 survivors working in healthcare may experience temporary hair loss.

A woman experienced total hair loss after an HPV vaccine, but treatment helped regrow her hair.

The marine protein complex, Viviscal®, was found to effectively reduce hair loss and improve hair, skin, and nails quality in women.

Hair loss and mental health issues like anxiety and insomnia affect each other, impacting quality of life.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Survivors of severe COVID-19 need ongoing care to manage lasting health issues.